ReviewCancers2023

Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy.

Michael P Randall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.